ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Astrana Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.90+0.09 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
Astrana Health, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Care Partners | $3.63B | $3.33B | $3.02B | $2.78B | $2.34B | $2.17B | $1.95B | $1.63B | $1.49B | $1.35B | $1.28B | $1.23B | 94.5% | +55.5% |
| Care Enablement | $339.54M | $294.85M | $246.66M | $212.88M | $166.47M | $161.74M | $155.45M | $143.75M | $139.73M | $138.53M | $135.82M | $133.40M | 8.8% | +104.0% |
| Care Delivery | $338.73M | $302.43M | $250.74M | $195.02M | $142.87M | $139.34M | $136.67M | $138.42M | $132.66M | $124.17M | $117.94M | $107.99M | 8.8% | +137.1% |
| Other | – | – | – | – | – | – | – | – | $539.00K | $696.00K | $937.00K | $1.00M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Care Partners | $143.40M | $150.21M | $154.97M | $138.12M | $151.62M | $142.26M | $141.24M | $123.54M | $125.09M | $112.60M | $91.72M | $104.06M | -5.4% |
| Care Enablement | $70.89M | $56.34M | $39.72M | $30.31M | $13.22M | $18.30M | $18.27M | $15.98M | $16.12M | $16.84M | $19.08M | $23.12M | +436.2% |
| Care Delivery | -$6.98M | -$1.87M | -$2.02M | -$2.11M | -$2.45M | -$2.77M | $103.00K | $7.54M | $7.86M | $6.60M | $5.87M | -$88.00K | +185.6% |
| Other | – | – | – | – | – | – | – | – | -$1.79M | -$2.63M | -$3.11M | -$2.54M | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capitation, net | $3.52B | $3.23B | $2.92B | $2.68B | $2.25B | $2.07B | $1.86B | $1.55B | $1.42B | $1.28B | $1.22B | $1.16B | 91.7% | +56.9% |
| Third-Party | $140.68M | $135.58M | $112.64M | $80.59M | $59.20M | $61.28M | $62.33M | $73.03M | $70.23M | $63.53M | $59.66M | $55.04M | 3.7% | +137.6% |
| Risk pool settlements and incentives | $90.61M | $84.19M | $86.20M | $89.35M | $80.33M | $83.34M | $86.22M | $72.43M | $65.67M | $67.38M | $63.47M | $64.14M | 2.4% | +12.8% |
| Management fee income | $54.40M | $43.77M | $30.39M | $25.65M | $13.18M | $12.21M | $13.98M | $14.82M | $21.97M | $32.86M | $38.68M | $42.89M | 1.4% | +312.6% |
| Intersegment | $33.60M | $29.73M | $28.28M | $22.51M | $20.03M | $18.90M | $15.22M | $13.02M | $10.61M | $8.68M | $9.24M | $6.45M | 0.9% | +67.8% |
By region
From the segment and revenue-disaggregation notes of Astrana Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.